POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,491,804 | +63.8% | 3,567,985 | +21.1% | 2.58% | +60.5% |
| Q2 2023 | $5,184,868 | -37.4% | 2,945,948 | +9.5% | 1.60% | -53.1% |
| Q1 2023 | $8,283,047 | -29.9% | 2,689,301 | +20.6% | 3.42% | +1.1% |
| Q4 2022 | $11,819,000 | +31.1% | 2,230,000 | -12.7% | 3.38% | +10.9% |
| Q3 2022 | $9,017,000 | +818.2% | 2,554,277 | +571.1% | 3.05% | +909.9% |
| Q2 2022 | $982,000 | -8.6% | 380,606 | +58.8% | 0.30% | -32.0% |
| Q1 2022 | $1,074,000 | -32.9% | 239,696 | +2.0% | 0.44% | -31.5% |
| Q4 2021 | $1,600,000 | – | 234,932 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |